| 000 | 01728 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516042521.0 | ||
| 264 | 0 | _c20111104 | |
| 008 | 201111s 0 0 fre d | ||
| 022 | _a1769-6917 | ||
| 024 | 7 |
_a10.1684/bdc.2011.1382 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLevy, Antonin | |
| 245 | 0 | 0 |
_a[Cell cycle, mitosis and therapeutic applications]. _h[electronic resource] |
| 260 |
_bBulletin du cancer _cOct 2011 |
||
| 300 |
_a1037-45 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAneuploidy |
| 650 | 0 | 4 |
_aApoptosis _xgenetics |
| 650 | 0 | 4 | _aAtaxia Telangiectasia Mutated Proteins |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 |
_aCell Cycle Proteins _xphysiology |
| 650 | 0 | 4 | _aCheckpoint Kinase 1 |
| 650 | 0 | 4 | _aCheckpoint Kinase 2 |
| 650 | 0 | 4 |
_aDNA Damage _xphysiology |
| 650 | 0 | 4 |
_aDNA Repair _xgenetics |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xphysiology |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 | _aGenomic Instability |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterphase _xphysiology |
| 650 | 0 | 4 |
_aMitosis _xdrug effects |
| 650 | 0 | 4 |
_aMolecular Targeted Therapy _xmethods |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aProtein Kinases _xphysiology |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xphysiology |
| 650 | 0 | 4 |
_aSignal Transduction _xphysiology |
| 650 | 0 | 4 |
_aTumor Suppressor Proteins _xphysiology |
| 700 | 1 | _aAlbiges-Sauvin, Laurence | |
| 700 | 1 | _aMassard, Christophe | |
| 700 | 1 | _aSoria, Jean-Charles | |
| 700 | 1 | _aDeutsch, Eric | |
| 773 | 0 |
_tBulletin du cancer _gvol. 98 _gno. 9 _gp. 1037-45 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1684/bdc.2011.1382 _zAvailable from publisher's website |
| 999 |
_c20924781 _d20924781 |
||